RECRUITING Not applicable ClinicalTrials.gov

Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration

Sponsor: Hackensack Meridian Health • ClinicalTrials.gov ID: NCT07442669

Registry updated: 2026-08-19

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This prospective randomized controlled study aims to determine if using a lung ultrasound score can lead to a faster diagnosis of severe respiratory distress syndrome and quicker administration of surfactant in moderately and late-preterm infants. The research will involve 100 infants, with 67 in the prospective group and 33 serving as controls. The primary goal is to shorten the time to treatment for these vulnerable newborns. The study will also assess whether this ultrasound-guided approach improves short-term respiratory outcomes. These secondary objectives include measuring any decrease in the need for and duration of mechanical ventilation, the length of non-invasive respiratory support, and the overall need for oxygen. The study population includes infants born between 27 and 34 6/7 weeks of gestation who are admitted to the NICU. Each participant will be monitored from birth until they are discharged or transferred. This research aligns with a growing body of evidence suggesting that lung ultrasound can be a valuable tool in neonatal care, potentially leading to earlier and more precise treatment for respiratory distress syndrome.

Interventions

Lung ultrasound (Diagnostic test)
Lung ultrasounds informing the decision-making on the Surfactant Administration

Eligibility criteria

Inclusion Criteria: * Inborn at 27 0/7 to 34 6/7 weeks of gestational age * Spontaneously breathing at birth but requiring non-invasive respiratory support * RDS diagnosed on chest x-ray (diffuse, bilateral, fine granular opacities in lungs, air bronchograms) or were at risk of developing RDS Exclusion Criteria: * Outborn * Endotracheal intubation in the delivery room or within 2 hours of life * Surfactant in the delivery room as part of advanced resuscitation * Presence of major congenital malformations or chromosomal anomalies * Hydrops fetalis * Inherited disorders of metabolism * Air leak syndrome (pneumothorax, pneumomediastinum) prior to surfactant administration, congenital diaphragmatic hernia, congenital pneumonia, meconium aspiration syndrome * Infants in extremis not expected to survive

Conditions

Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome in Premature Infant

Locations

Hackensack Univeristy Medical Center — Hackensack, New Jersey, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment